Eisai presented latest data regarding drug candidate BAN2401 at CTAD 2020 ...Middle East

STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- BioArctic AB (publ) [Nasdaq Stockholm: BIOA B] announced today data on the drug candidate BAN2401 (lecanemab), which were presented by the company's partner Eisai at the Clinical Trials on Alzheimer's Disease conference (CTAD), November 4-7. The...

Read More Details
Finally We wish PressBee provided you with enough information of ( Eisai presented latest data regarding drug candidate BAN2401 at CTAD 2020 )

Also on site :

• Heartbreaking letters Camp Mystic children wrote to their family arrive days after they died in Texas floods
• Nine things over 60s should do each week to stay young (including kitchen dancing)
• Watch- Shubman Gill reacts as Ravindra Jadeja teases him in front of Sara Tendulkar